The stock of Cybin Inc (CYBN) has seen a 5.14% increase in the past week, with a -11.59% drop in the past month, and a 43.91% flourish in the past quarter. The volatility ratio for the week is 9.14%, and the volatility levels for the past 30 days are at 11.28% for CYBN. The simple moving average for the past 20 days is -14.11% for CYBN’s stock, with a 12.45% simple moving average for the past 200 days.

Is It Worth Investing in Cybin Inc (AMEX: CYBN) Right Now?

Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


The average price point forecasted by analysts for Cybin Inc (CYBN) is $4.83, which is $4.38 above the current market price. The public float for CYBN is 183.85M, and currently, short sellers hold a 5.86% ratio of that floaft. The average trading volume of CYBN on November 20, 2023 was 4.92M shares.

CYBN) stock’s latest price update

The stock price of Cybin Inc (AMEX: CYBN) has surged by 0.18 when compared to previous closing price of 0.45, but the company has seen a 5.14% gain in its stock price over the last five trading sessions. Business Wire reported 2023-10-06 that TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that its abstract describing a comprehensive structure-activity relationship study of a series of novel serotonergic phenethylamines has been selected for presentation at the Neuropsychiatric Drug Development Summit taking pla.

CYBN Trading at -11.82% from the 50-Day Moving Average

After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.02% of loss for the given period.

Volatility was left at 11.28%, however, over the last 30 days, the volatility rate increased by 9.14%, as shares sank -7.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.36% upper at present.

During the last 5 trading sessions, CYBN rose by +5.14%, which changed the moving average for the period of 200-days by -2.15% in comparison to the 20-day moving average, which settled at $0.5222. In addition, Cybin Inc saw 51.46% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for CYBN

The total capital return value is set at -82.83, while invested capital returns managed to touch -76.36. Equity return is now at value -91.42, with -81.20 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 4.09.


In a nutshell, Cybin Inc (CYBN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.